Details of the Target
General Information of Target
Target Site Mutations in Different Cell Lines
Probe(s) Labeling This Target
ABPP Probe
| Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
|---|---|---|---|---|---|
|
DBIA Probe Info |
![]() |
C69(9.89) | LDD0209 | [1] | |
Competitor(s) Related to This Target
The Interaction Atlas With This Target
The Drug(s) Related To This Target
Approved
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Brentuximab Vedotin | Monoclonal antibody | D03TIS | |||
Phase 2
Phase 1
Investigative
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| H22xki-4 | Antibody | D0LE2E | |||
| Vt-362 | . | D02SJG | |||
| Xmab 2513 | . | DB06324 | |||
Discontinued
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Ber-h2/Saporin | Antibody | D0A9QL | |||
References

